We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
J. Curtis Nickel

J. Curtis Nickel MD, FRCSC

Professor of Urology, Queen's University, Tier 1 Canada Research Chair in Urologic Pain and Inflammation Kingston General Hospital Kingston, Ontario, Canada


Dr. Nickel reports disclosures as a consultant and from a scientific study/trial from Glaxo-Smith-Kline, Taris Biomedical, Pfizer, and Eli Lilly. He is a lecturer for Eli Lilly and Astellas, and has participated in scientific studies/trials for Johnson&Johnson and Aquinox. He is a consultant for Farr Labs, Astellas, Trillium Therapeutics, Auxillium, Ferring, and Tribute.